| | | | | | | | | Sponsored | | Join COLA’s Laboratory Enrichment Forum in Nashville, Tennessee May 6-8, 2026, to explore laboratory leadership and expand your understanding of regulatory compliance. Gain practical insights while earning CEUs, engage in interactive sessions including a Laboratory Director track, network with peers, hear from distinguished speakers and connect with fellow Laboratory Science Professionals. |
|
|
| | |
| |
| | |
|
|
| | | | | | In this online exclusive Q&A, Roshan Patel, Founder & CEO of Arrow, discusses laboratory testing claim denials and best practices in minimizing revenue loss with MLO Editor-in-Chief, Christina Wichmann. |
|
|
|
| |
| | |
|
|
| | | | | | The Association for Diagnostics and Laboratory Medicine (ADLM) has published an article highlighting the impact those who hold Doctor of Clinical Laboratory Science (DCLS) degrees have on patient care, hoping to grow interest in the program. |
|
|
|
| |
| | |
|
|
| | | | | | Siemens Healthineers and World Athletics have joined forces to inform medical teams how point-of-care testing (POCT) and diagnostic imaging can enhance athlete safety at endurance events and redefine how event medical teams support athletes and event spectators. |
|
|
|
| |
| | |
|
|
| | | | | | Sponsored | | Ignite excellence with Bio-Rad’s Essential Toolkit! Access tailored content and intuitive tools to master quality control and conquer lab challenges. |
|
|
| | |
| |
| | |
|
|
| | | | | | Our January CE explores the evolution of point-of-care testing (POCT), highlighting technological advancements, diverse clinical applications, and its critical role in rapid diagnostics across hospital, emergency, disaster, and athletic environments to improve patient care and workflow efficiency. |
|
|
|
| |
| | |
|
|
| | | | | | Medical Laboratory Observer (MLO) will reveal our Lab of the Year (LOY) winners in the April 2026 issue, recognizing laboratories driving excellence in patient care. Let us know what winning would mean for your lab in our latest poll! |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|